These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35434614)

  • 1. Studies of IGF-I and Klotho Protein in Relation to Anabolic-Androgenic Steroid and Growth Hormone Administrations.
    Lehtihet M; Stephanou C; Börjesson A; Bhuiyan H; Pohanka A; Ekström L
    Front Sports Act Living; 2022; 4():829940. PubMed ID: 35434614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Administration of growth hormone and nandrolone decanoate alters mRNA expression of the GABAB receptor subunits as well as of the GH receptor, IGF-1, and IGF-2 in rat brain.
    Grönbladh A; Johansson J; Nyberg F; Hallberg M
    Growth Horm IGF Res; 2014; 24(2-3):60-6. PubMed ID: 24480470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone induced increase in serum IGFBP-3 level is reversed by anabolic steroids in substance abusing power athletes.
    Karila T; Koistinen H; Seppälä M; Koistinen R; Seppälä T
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):459-63. PubMed ID: 9876343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis.
    Christou MA; Christou PA; Markozannes G; Tsatsoulis A; Mastorakos G; Tigas S
    Sports Med; 2017 Sep; 47(9):1869-1883. PubMed ID: 28258581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Supra-physiological doses of anabolic androgenic steroids impact erythropoietin and blood parameters.
    Heiland CE; Schickel Y; Lehtihet M; Börjesson A; Ekström L
    Drug Test Anal; 2023 Jun; 15(6):599-604. PubMed ID: 36730044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-like growth factor-1 is associated with regulation of the luteinizing hormone production in men receiving androgen deprivation therapy with gonadotropin-releasing hormone analogues for localized prostate cancer.
    Hara N; Takizawa I; Isahaya E; Nishiyama T; Hoshii T; Ishizaki F; Takahashi K
    Urol Oncol; 2012 Sep; 30(5):596-601. PubMed ID: 21458314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant human growth hormone in abstinent androgenic-anabolic steroid use: psychological, endocrine and trophic factor effects.
    Graham MR; Davies B; Kicman A; Cowan D; Hullin D; Baker JS
    Curr Neurovasc Res; 2007 Feb; 4(1):9-18. PubMed ID: 17311540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum α-klotho levels are not informative for the evaluation of growth hormone secretion in short children.
    Meazza C; Elsedfy HH; Khalaf RI; Lupi F; Pagani S; Kholy ME; Tinelli C; Radetti G; Bozzola M
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1055-1059. PubMed ID: 28902627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D receptor rs2228570 polymorphism is associated with LH levels in men exposed to anabolic androgenic steroids.
    Björkhem-Bergman L; Lehtihet M; Rane A; Ekström L
    BMC Res Notes; 2018 Jan; 11(1):51. PubMed ID: 29351807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The aging suppressor klotho: a potential regulator of growth hormone secretion.
    Shahmoon S; Rubinfeld H; Wolf I; Cohen ZR; Hadani M; Shimon I; Rubinek T
    Am J Physiol Endocrinol Metab; 2014 Aug; 307(3):E326-34. PubMed ID: 24939736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinal studies of putative growth hormone (GH) biomarkers and hematological and steroidal parameters in relation to 2 weeks administration of human recombinant GH.
    Sieckmann T; Elmongy H; Ericsson M; Bhuiyan H; Lehtihet M; Ekström L
    Drug Test Anal; 2020 Jun; 12(6):711-719. PubMed ID: 32115881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of growth hormone replacement therapy on IGF-related parameters and on the pituitary-gonadal axis in GH-deficient males. A double-blind, placebo-controlled crossover study.
    Juul A; Andersson AM; Pedersen SA; Jørgensen JO; Christiansen JS; Groome NP; Skakkebaek NE
    Horm Res; 1998; 49(6):269-78. PubMed ID: 9623518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Klotho response to treatment with growth hormone and the role of IGF-I as a mediator.
    Rubinek T; Shahmoon S; Shabtay-Orbach A; Ben Ami M; Levy-Shraga Y; Mazor-Aronovitch K; Yeshayahu Y; Doolman R; Hemi R; Kanety H; Wolf I; Modan-Moses D
    Metabolism; 2016 Nov; 65(11):1597-1604. PubMed ID: 27733247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex steroids, growth hormone, insulin-like growth factor-1: neuroendocrine and metabolic regulation in puberty.
    Mauras N; Rogol AD; Haymond MW; Veldhuis JD
    Horm Res; 1996; 45(1-2):74-80. PubMed ID: 8742123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents.
    Börjesson A; Lehtihet M; Andersson A; Dahl ML; Vicente V; Ericsson M; Ekström L
    Drug Test Anal; 2020 Apr; 12(4):514-523. PubMed ID: 31925932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term perturbation of endocrine parameters and cholesterol metabolism after discontinued abuse of anabolic androgenic steroids.
    Gårevik N; Strahm E; Garle M; Lundmark J; Ståhle L; Ekström L; Rane A
    J Steroid Biochem Mol Biol; 2011 Nov; 127(3-5):295-300. PubMed ID: 21884791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Peculiarity of recovery of the hypothalamic-pituitary-gonadal (hpg) axis, in men after using androgenic anabolic steroids].
    Lykhonosov MP; Babenko AY; Makarin VA; Fedotov YN
    Probl Endokrinol (Mosk); 2020 Aug; 66(1):104-112. PubMed ID: 33351319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Klotho and the Growth Hormone/Insulin-Like Growth Factor 1 Axis: Novel Insights into Complex Interactions.
    Rubinek T; Modan-Moses D
    Vitam Horm; 2016; 101():85-118. PubMed ID: 27125739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A; Gedik O
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinally monitoring of P-III-NP, IGF-I, and GH-2000 score increases the probability of detecting two weeks' administration of low-dose recombinant growth hormone compared to GH-2000 decision limit and GH isoform test and micro RNA markers.
    Lehtihet M; Bhuiyan H; Dalby A; Ericsson M; Ekström L
    Drug Test Anal; 2019 Mar; 11(3):411-421. PubMed ID: 30223291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.